News
Mutation in DOCK11 gene explains rare disorder in immune system regulation
Researchers from the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital participate in an international study, published in the prestigious scientific journal New England Journal of Medicine, which describes for the first time a new disease of the immune system caused by a mutation of the DOCK11 gene.
A study led by Sant Joan de Déu shows promising results for a new treatment for childhood cerebral adrenoleukodystrophy
An international study led by Sant Joan de Déu explores the first oral therapy to slow childhood cerebral adrenoleukodystrophy, a devastating rare disease.
New alliance between the Institut de Recerca Sant Joan de Déu and the BSC to advance pediatric research
Both entities will establish joint research groups with the aim of consolidating Barcelona as a European benchmark in child biomedical research.
The Institut de Recerca Sant Joan de Déu drives the first in-person meeting of the cancer Survivorship Network of Expertise of the JANE2 project
On May 9th, the Institut de Recerca Sant Joan de Déu (IRSJD) brought together the leaders of the Survivorship Network of Expertise, a network framed within the Joint Action on Network of Expertise (JANE2) project, one of the pillars of the European Beating Cancer Plan. During the meeting, key challenges and activities to advance care for cancer survivors in Europe were addressed, and a "working definition" was proposed to help establish an integrative care model for survivors.
Agenda
TECSAM | Descobreix CIBERSAM i les oportunitats de col·laboració en Salut Mental
Esther Jiménez: Adjunta a la direcció científica de CIBERSAM.
Defensa tesi doctoral: Pablo Táboas Outón
"'An epigenetic approach for Ewing sarcoma patients"
Interviews
Manel González-Piñero
Headof Innovation at CREB UPC and XarTEC SALUT
"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."
Read more More Interviews
